DOCSLIB.ORG

| St |-> PEG | Sugar

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
| St |-> PEG | Sugar US 2015O157721A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0157721 A1 W (43) Pub. Date: Jun. 11, 2015 (54) POLYMER-CARBOHYDRATE CONJUGATES (52) U.S. Cl. FOR DRUG DELVERY TECHNOLOGY CPC ................. A61K 47/26 (2013.01); A61K 47/28 (2013.01) (71) Applicant: Nian Wu, North Brunswick, NJ (US) (57) ABSTRACT (72) Inventor: Nian Wu, North Brunswick, NJ (US) The invention comprises compounds, methods of making, s s and methods of using. The compounds may have a linear or cylic backbone and three or four appended functional groups: (21) Appl. No.: 14/561,219 one or two lipohilic compounds including sterols or "fat soluble' vitamins, one or two hydrophilic polymer, and one or two carbohydrate. A group of polymer-carbohydrate con (22) Filed: Dec. 5, 2014 jugates having a central backbone and three appended func tional groups are disclosed wherein one lipophilic compound is void of both steroid acids. The conjugate may have fatty Related U.S. Application Data acids as the primary lipophilic carrier, one hydrophilic poly (60) Provisional application No. 61/912,228, filed on Dec. mer, and one carbohydrate. Specific functional groups may be 5, 2013 selected for specific applications in formulating pharmaceu s ticals, cosmetics, nutriceuticals, and the like. Typical cou pling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation Publication Classification or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the back (51) Int. Cl. bone and functional groups may also be selected to modify A6 IK 47/26 (2006.01) the carriers or center backbones for the coupling reactions A6 IK 47/28 (2006.01) and optimize performance of the conjugates. P s\ X,\ x. Xs X-B Xis aX-B and/orf X. S X7-- - H Backbone1 Sugar"NBackbone1 H Sugar \ and/or \ PEG D PEG PEG H PEG Sugar belt- Sugar isitor H -heir | st and/or |-> PEG and/or | Sugar D D D Patent Application Publication Jun. 11, 2015 US 2015/O157721 A1 P s x," X X- b. *is SA x and/or X2 2H--- Ef H H 1.Backbone1 S ugars ackbone1 Sugar \ and/or / PEG D PEG PEG PEG Sugar net- Sugar her i-ester } s and/or } PEG and/or | Sugar D D D Figure : Commercial PEG-carbohydrate conjugates O 4 3. 13 18 3) 34 Time (hr) Figure 2 US 2015/O157721 A1 Jun. 11, 2015 POLYMER-CARBOHYDRATE CONUGATES tively high vehicle contents which may cause side effects FOR DRUG DELIVERY TECHNOLOGY Such as allergic reactions “Cremophor-based paclitaxel 0001. This application claims priority to the provisional chemo drug triggers fatal allergic reactions. The Medical patent application Ser. No. 61/912,228, entitled “Polymer News. 9 June 2009. Carbohydrate Conjugates for Drug Delivery Technology’ 0005. In the design of safe and biocompatible delivery filed in the U.S. Patent and Trademark Office on Dec. 5, 2013, systems, several important factors may be taken into account by Nian Wu. including high solubilization properties and retaining power of the carrier and appropriate Surface characteristics to permit FIELD OF THE INVENTION interactions with potential targeting tissue sites or cell mem 0002 The present invention relates to polymer-carbohy brane permeations. drate conjugates, detailed and specific disclosures are given for synthetic polyethyleneglycol (PEG)-carbohydrate conju 0006. The important role of sugars in many specific inter gates with sterols or so called “fat solable' vitamins ("lipo actions in living systems is well recognized. Large molecular vitamin') as the lipophilic carriers excluding both steroid weight carriers such as proteins or liposomes may be modi acids and fatty acids as the primary lipophilic component in fied with sugars for specific drug delivery (Monsigny M, the conjugates and preferably having Substantially monodis Roche AC, Midoux P and Mayer R. Adv. Drug Delivery Rev., perse PEG chains ifused for intravenous drug administration. 14 (1994): 1-24; Palomino E. Adv. Drug Delivery Rev., 13 More particularly, the present invention relates to novel poly (1994)311-323. Lipid-sugar particles have been used for mer-carbohydrate conjugates having sterols or steroid alco drug delivery to the brain for providing prolonged duration hols or lipophilic Vitamin component to increase lipophilic local anesthesia when injected at the Sciatic nerve in rats characters in the hydrophobic portion or polymer-carbohy Kohane DS, Lipp M. Kinney R. Lotan N. Langer R., Pharm. drate conjugates and their use for drug delivery, cosmetics Res. 17 (2000) 1243-1249. Since sugar-lipids are composed and other purposes. of materials that occur naturally in the human body Suggests potential advantages over Some other polymer-based con BACKGROUND OF INVENTION trolled-release terms of biocompatibility Kohane DS, Lipp 0003 Polyethyleneglycol (PEG) is widely used as a water M. Kinney R. Anthony D, Lotan N. Langer R. J. Biomed. soluble carrier for polymer-drug conjugates. PEG is undoubt Mat. Res. 59 (2002) 450-459; Menei P. Daniel V. Montero edly the most studied and applied synthetic polymer in the Menei C, Brouillard M. Pouplard-Barthelaix A, Benoit JP, biomedical field Duncan, R. Nature Rev. Drug Discov. 2003, Biomaterials, 14 (1993) 470-478. Lipid-sugars have a good 2, 347-360. As an uncharged, water-soluble, nontoxic, non biocompatibility as shown by the results of the in vitro and in immunogenic polymer, PEG is an ideal material for biomedi vivo studies Kohane DS, Lipp M. Kinney R. Anthony D, cal applications. Covalent attachment of PEG to biologically Lotan N, Langer R.J. Biomed. Mat. Res. 59 (2002) 450-459). active compounds is often useful as a technique for alteration and control of biodistribution and pharmacokinetics, mini 0007 Sterol is classified as a lipid in one of the eight lipid mizing toxicity of these compounds Duncan, R. and categories Fahy E. Subramaniam S. Brown H A, et al. Kopecek, J., Adv. Polym. Sci. 57 (1984), 53-101). PEG pos (2005). A comprehensive classification system for lipids”. J. sesses several beneficial properties: Very low toxicity Pang, Lipid Res. 46 (5): 839-61. The lipid classification scheme is S. N.J., J. Am. Coil. Toxicol, 12 (1993), 429–456, excellent chemically based and driven by the distinct hydrophobic and solubility in aqueous solutions Powell, G. M., Handbook of hydrophilic elements that compose the lipid. Sterols and Water Soluble Gums and Resins, R. L. Davidson (Ed.), Ch. 18 related compounds play essential roles in the physiology of (1980), MGraw-Hill, New York, and extremely low immu eukaryotic organisms are a Subgroup of the steroids. They nogenicity and antigenicity Dreborg, S. Crit. Rev. Ther: Drug occur naturally in plants, animals, and fungi, the most famil Carrier Syst., 6 (1990),315-365). The polymer is known to be iar type of animal sterol is cholesterol. Cholesterol is vital to non-biodegradable, yet it is readily excretable after adminis animal cell membrane structure and function and forms part tration into living organisms. In vitro study showed that its of the cellular membrane in animals, where it affects the cell presence in aqueous Solutions has shown no deleterious effect membrane's fluidity and serves as secondary messenger in on protein conformation or activities of enzymes. PEG also developmental signaling Alberts B. Johnson A. Lewis J. Raff exhibits excellent pharmacokinetic and biodistribution M. Roberts K, and Walter P (2002). Molecular biology of the behavior. Yamaoka, T., Tabata, Y. and Ikada, Y., J. Pharm. cell. 4"Edition, NewYork: Garland Science. p. 1874). For the Sci. 83 (1994), 601-606). distinction and clarity, sterols or steroid alcohols ultilized in 0004 Over last three decades, some of promising drug the present invention, as showed in General Formula 1, are carriers that have been investigated in Systemic delivery sys not water soluble and different chemical compounds from tems includes liposomes, polymeric nanoparticles, polymeric those of steroid acids such as cholic acid or other bile acids. micelles, ceramic nanoparticles and dendrimers (Cherian et al. Drug. Dev. Ind. Pharm, 26: (2000) 459-463; Lian and Ho. J. Pharm. Sci, 90 (2001) 66T-680; Adams et al. Pharm. Sci,92 (2003) 1343-1355; Na et al. Eur: J. Med Chem. 41 (2006) 670-674; Kaur et al. J. Control. Rel, 127(2008) 97-109). Systemic drug delivery may be achieved by intravenous or intraperipheral injection and therefore is noninvasive. The drugs may be administered repeatedly as needed. However, in HO order to achieve therapeutic concentrations at the target site, systemic administration requires large dosages with rela US 2015/O157721 A1 Jun. 11, 2015 General Formula 1: Basic Structure of Sterols in the reasons: the pi bond electrons are more polarizable, thus Invention contributing to instantaneous dipole moments, and the vinylic bond tends to be slightly polar, contributing to the permanent 0008. The present invention compromises one of the three dipole moment. In a symmetrical trans disubstituted double carrier groups consisting of a sterol or Sterol-like or "fat bonds, the sum of the dipole moments is Zero. In the analo soluble' vitamin component including but not limited to cho gous cis double bonds, the vector sum of the two dipoles is lesterol, Stigmasterol, ergosterol, hopanoids, phytosterol, directed perpendicular to the double bond. This results in a sitosterol, campesterol, brassicasterol, avenasterol adosterol, non-Zero molecular dipole. The permanent dipole results in and stanols (saturated Steroid alcohols or hydrogenated Ste an increased boiling temperature and lower melting points. rols). Sterols are biological importance as a highly compat Lipophilic vitamins have a general structure of conjugated ible vehicle for drug delivery, for instance cholesterol makes double bonds which increase non-polar interactions with up about 10-50 percent of the total lipid in natural cell mem hydrophobic molecules.
Load more

Recommended publications
  • And Chemical Constituents(Tobacco Leaves)
    67th TSRC Study of correlation between volatile 2013_TSRC51_GengZhaoliang.pdf carbonyls in cigarette mainstream smoke and chemical constituents in tobacco leaves GENG Zhao-liang Guizhou Academy of Tobacco Science, Guiyang, Guizhou, China 2013.09 TSRC2013(67) - Document not peer-reviewed Introductions Carbonyls Main source of Volatile carbonyls 2013_TSRC51_GengZhaoliang.pdf The impact on people’s health Resulting thinking Experimental Section Materials and Dectections Results and Analysis Different chemical constituents in tobaccl leaves The rule of carbonyl compounds emission Correlation of carbonyls and chemical constituents The Follow-up Consideration TSRC2013(67) - Document not peer-reviewed INTRODUCTIONS Carbonyls (aldehydes and ketones) are an important class of volatile organic pollutants, including formaldehyde, aldehyde, 2013_TSRC51_GengZhaoliang.pdf acetone, acrolein, propionaldehyde, crotonaldehyde, butyl aldehyde. O O O O H H H H O O O H H People pay more attention as their important role in phytochemistry and for the toxic air contaminants which can cause suspected carcinogens, eye irritants and mutagens to human. TSRC2013(67) - Document not peer-reviewed The main sources of Volatile carbonyls are from waste incineration, cooking oil fume(COF), factory and motobile exhaust, etc. 2013_TSRC51_GengZhaoliang.pdf Unfortunately, cigarette smoke also contains many volatile carbonyls. TSRC2013(67) - Document not peer-reviewed What about the impact of Volatile Carbonyl Compounds on people’s health? • Compared with nitrosamines, aromatic amines, nitrogen oxides 2013_TSRC51_GengZhaoliang.pdf and benzopyrene, Volatile Carbonyl Compounds have higher contents in mainstream cigarette smoke. • The low molecular aldehydes, such as acrolein, formaldehyde, acetaldehyde and crotonaldehyde in carbonyl compounds, have not only strong pungent odor but also cilia toxicity. That is, they can risk lung irritation.
    [Show full text]
  • Uvic Thesis Template
    Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in the Department of Biochemistry and Microbiology Kaleigh Giles, 2014 University of Victoria All rights reserved. This thesis may not be reproduced in whole or in part, by photocopy or other means, without the permission of the author. ii Supervisory Committee Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger (Department of Biochemistry and Microbiology) Departmental Member Dr. Fraser Hof (Department of Chemistry) Outside Member iii Abstract Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger, Department of Biochemistry and Microbiology Departmental Member Dr. Fraser Hof, Department of Chemistry O utside Member Agarose and porphyran are related galactans that are only found within red marine algae. As such, marine microorganisms have adapted to using these polysaccharides as carbon sources through the acquisition of unique Carbohydrate Active enZymes (CAZymes). A recent metagenome study of the microbiomes from a Japanese human population identified putative CAZymes in several bacterial species, including Bacteroides plebeius that have significant amino acid sequence similarity with those from marine bacteria. Analysis of one potential CAZyme from B. plebeius (BpGH50) is described here. While displaying up to 30% sequence identity with β-agarases, BpGH50 has no detectable agarase activity. Its crystal structure reveals that the topology of the active site is much different than previously characterized agarases, while containing the same core catalytic machinery.
    [Show full text]
  • Glycoconjugates
    Background Information on Glycoconjugates Richard D. Cummings, Ph.D. Director, National Center for Functional Glycomics Professor Department of Surgery Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA 02114 Tel: (617) 735-4643 e-mail: [email protected] For General Reference On-Line See: Essentials of Glycobiology (2nd Edition) Varki, Cummings, Esko, Freeze, Stanley, Bertozzi, Hart and Etzler) http://www.ncbi.nlm.nih.gov/books/NBK1908/ Mammalian Cells are Covered with Glycoconjugates GLYCOSAMINOGLYCANS/ GLYCOPROTEINS PROTEOGLYCANS GLYCOLIPIDS NUCLEAR/CYTOPLASMIC GLYCOPROTEINS 2 Mammalian Glycoconjugates are Recognized by a Wide Variety of Specific Proteins GLYCAN-BINDING PROTEIN (GBP) GBP ANTIBODY TOXIN GBP GBP VIRUS 7 ANTIBODY GBP MICROBE TOXIN 3 Glycosylation Pathways 4 Glycosylation Pathways 5 Glycoconjugates, Which are Molecules Containing Sugars (Monosaccharides) Linked Within Them, are the Major Constituents of Animal Cell Membranes (Glycocalyx) and Secreted Material: See Different Classes of Glycoconjugates Below in Red Boxes PROTEOGLYCANS GLYCOSAMINOGLYCANS GLYCOSAMINOGLYCANS GLYCOPROTEINS GPI-ANCHORED GLYCOPROTEINS GLYCOLIPIDS outside Cell Membrane cytoplasm Essentials of Glycobiology, 3rd Edition CYTOPLASMIC GLYCOPROTEINS Chapter 1, Figure 6 Glycans are as Ubiquitous as DNA/RNA and Appear to Represent Greater Molecular Diversity 7 Big Picture: Nucleotide Sugars Connection of • UDP-Glc, • UDP-Gal, • UDP-GlcNAc, Glycoconjugate • UDPGalNAc, • UDP-GlcA, Biosynthesis • UDP-Xyl, • GDP-Man, • GDP-Fuc, to Intermediary • CMP-Neu5Ac used for synthesizing Metabolism glycoconjugates, e.g, glycoproteins & glycolipids 8 Important Topics to Consider 1. The different types of monosaccharides found in animal cell glycoconjugates 2. The different types of glycoconjugates and their differences, e.g. glycoproteins, glycolipids 3. The nucleotide sugars, glycosyltransferases, glycosidases, transporters, endoplasmic reticulum, and Golgi in terms of their roles in glycoconjugate biosynthesis and turnover 4.
    [Show full text]
  • Collagen-Based Matrix Matrix Auf Der Basis Von Kollagen Matrice À Base De Collagène
    Europäisches Patentamt *EP000693523B1* (19) European Patent Office Office européen des brevets (11) EP 0 693 523 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C08H 1/06, A61L 27/00, of the grant of the patent: A61L 31/00 20.11.2002 Bulletin 2002/47 (21) Application number: 95111260.6 (22) Date of filing: 18.07.1995 (54) Collagen-based matrix Matrix auf der Basis von Kollagen Matrice à base de collagène (84) Designated Contracting States: • Noff, Matityahu AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL Rehovot 76228 (IL) PT SE (74) Representative: Grünecker, Kinkeldey, (30) Priority: 19.07.1994 IL 11036794 Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 (43) Date of publication of application: 80538 München (DE) 24.01.1996 Bulletin 1996/04 (56) References cited: (73) Proprietor: COL-BAR R & D LTD. DE-A- 4 302 708 FR-A- 2 679 778 Ramat-Gan 52290 (IL) US-A- 4 971 954 (72) Inventors: Remarks: • Pitaru, Sandu The file contains technical information submitted Tel-Aviv 62300 (IL) after the application was filed and not included in this specification Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 0 693 523 B1 Printed by Jouve, 75001 PARIS (FR) EP 0 693 523 B1 Description [0001] The present invention concerns a collagen-based matrix and devices comprising this matrix.
    [Show full text]
  • Intermediate Transfer Type Ink Jet Recording Method
    Europaisches Patentamt J European Patent Office © Publication number: 0 606 490 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC © Application number: 93914949.8 int. ci.5: B41J 2/01 @ Date of filing: 02.07.93 © International application number: PCT/JP93/00914 © International publication number: WO 94/01283 (20.01.94 94/03) © Priority: 02.07.92 JP 175384/92 Inventor: HOSONO, Yoshie 02.07.92 JP 175385/92 Seiko Epson Corporation, 02.07.92 JP 175386/92 3-5, Owa 3-chome 02.07.92 JP 175387/92 Suwa-shi, Nagano 392(JP) 16.10.92 JP 278938/92 Inventor: NAKAMURA, Hiroto 05.11.92 JP 296109/92 Seiko Epson Corporation, 05.11.92 JP 296110/92 3-5, Owa 3-chome 05.11.92 JP 296111/92 Suwa-shi, Nagano 392(JP) 06.01.93 JP 665/93 Inventor: KOIKE, Yoshiyuki Seiko Epson Corporation, © Date of publication of application: 3-5, Owa 3-chome 20.07.94 Bulletin 94/29 Suwa-shi, Nagano 392(JP) Inventor: MATSUZAKI, Makoto @ Designated Contracting States: Seiko Epson Corporation, CH DE FR GB IT LI NL SE 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Applicant: SEIKO EPSON CORPORATION Inventor: UEHARA, Fumie 4-1, Nishishinjuku 2-chome Seiko Shinjuku-ku Tokyo 163(JP) Epson Corporation, 3-5, Owa 3-chome © Inventor: FUJINO, Makoto Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, Inventor: ISHIBASHI, Osamu 3-5, Owa 3-chome Seiko Epson Corporation, Suwa-shi, Nagano 392(JP) 3-5, Owa 3-chome Inventor: KUMAGAI, Toshio Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Representative: Lewin, John Harvey Inventor: TSUKAHARA, Michinari Elkington and Fife Seiko Epson Corporation, Prospect House CO 8 Pembroke Road o 3-5, Owa 3-chome CO Suwa-shi, Nagano 392(JP) Sevenoaks, Kent TN13 1XR (GB) &) INTERMEDIATE TRANSFER TYPE INK JET RECORDING METHOD.
    [Show full text]
  • Camellia Japonica Leaf and Probable Biosynthesis Pathways of the Metabolome Soumya Majumder, Arindam Ghosh and Malay Bhattacharya*
    Majumder et al. Bulletin of the National Research Centre (2020) 44:141 Bulletin of the National https://doi.org/10.1186/s42269-020-00397-7 Research Centre RESEARCH Open Access Natural anti-inflammatory terpenoids in Camellia japonica leaf and probable biosynthesis pathways of the metabolome Soumya Majumder, Arindam Ghosh and Malay Bhattacharya* Abstract Background: Metabolomics of Camellia japonica leaf has been studied to identify the terpenoids present in it and their interrelations regarding biosynthesis as most of their pathways are closely situated. Camellia japonica is famous for its anti-inflammatory activity in the field of medicines and ethno-botany. In this research, we intended to study the metabolomics of Camellia japonica leaf by using gas chromatography-mass spectroscopy technique. Results: A total of twenty-nine anti-inflammatory compounds, occupying 83.96% of total area, came out in the result. Most of the metabolites are terpenoids leading with triterpenoids like squalene, lupeol, and vitamin E. In this study, the candidate molecules responsible for anti-inflammatory activity were spotted out in the leaf extract and biosynthetic relation or interactions between those components were also established. Conclusion: Finding novel anticancer and anti-inflammatory medicinal compounds like lupeol in a large amount in Camellia japonica leaf is the most remarkable outcome of this gas chromatography-mass spectroscopy analysis. Developing probable pathway for biosynthesis of methyl commate B is also noteworthy. Keywords: Camellia japonica, Metabolomics, GC-MS, Anti-inflammatory compounds, Lupeol Background genus Camellia originated in China (Shandong, east Inflammation in the body is a result of a natural response Zhejiang), Taiwan, southern Korea, and southern Japan to injury which induces pain, fever, and swelling.
    [Show full text]
  • Solanesol Biosynthesis in Plants
    Review Solanesol Biosynthesis in Plants Ning Yan *, Yanhua Liu, Hongbo Zhang, Yongmei Du, Xinmin Liu and Zhongfeng Zhang Tobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao 266101, China; [email protected] (Y.L.); [email protected] (H.Z.); [email protected] (Y.D.); [email protected] (X.L.); [email protected] (Z.Z.) * Correspondence: [email protected]; Tel.: +86-532-8870-1035 Academic Editor: Derek J. McPhee Received: 1 March 2017; Accepted: 22 March 2017; Published: 23 March 2017 Abstract: Solanesol is a non-cyclic terpene alcohol composed of nine isoprene units that mainly accumulates in solanaceous plants. Solanesol plays an important role in the interactions between plants and environmental factors such as pathogen infections and moderate-to-high temperatures. Additionally, it is a key intermediate for the pharmaceutical synthesis of ubiquinone-based drugs such as coenzyme Q10 and vitamin K2, and anti-cancer agent synergizers such as N-solanesyl- N,N′-bis(3,4-dimethoxybenzyl) ethylenediamine (SDB). In plants, solanesol is formed by the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway within plastids. Solanesol’s biosynthetic pathway involves the generation of C5 precursors, followed by the generation of direct precursors, and then the biosynthesis and modification of terpenoids; the first two stages of this pathway are well understood. Based on the current understanding of solanesol biosynthesis, we here review the key enzymes involved, including 1-deoxy-D-xylulose 5-phosphate synthase (DXS), 1-deoxy-D- xylulose 5-phosphate reductoisomerase (DXR), isopentenyl diphosphate isomerase (IPI), geranyl geranyl diphosphate synthase (GGPPS), and solanesyl diphosphate synthase (SPS), as well as their biological functions.
    [Show full text]
  • View a Copy of This Licence, Visit ​ Mmons.Org/Licen​ Ses/By/4.0/​
    Zhang et al. Microb Cell Fact (2021) 20:29 https://doi.org/10.1186/s12934-021-01523-4 Microbial Cell Factories TECHNICAL NOTES Open Access Synthesis of cembratriene-ol and cembratriene-diol in yeast via the MVA pathway Yu Zhang1, Shiquan Bian1, Xiaofeng Liu1, Ning Fang1, Chunkai Wang1, Yanhua Liu1, Yongmei Du1, Michael P. Timko2, Zhongfeng Zhang1* and Hongbo Zhang1* Abstract Background: Cembranoids are one kind of diterpenoids with multiple biological activities. The tobacco cem- bratriene-ol (CBT-ol) and cembratriene-diol (CBT-diol) have high anti-insect and anti-fungal activities, which is attract- ing great attentions for their potential usage in sustainable agriculture. Cembranoids were supposed to be formed through the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway, yet the involvement of mevalonate (MVA) pathway in their synthesis remains unclear. Exploring the roles of MVA pathway in cembranoid synthesis could contribute not only to the technical approach but also to the molecular mechanism for cembranoid biosynthesis. Results: We constructed vectors to express cembratriene-ol synthase (CBTS1) and its fusion protein (AD-CBTS1) containing an N-terminal GAL4 AD domain as a translation leader in yeast. Eventually, the modifed enzyme AD- CBTS1 was successfully expressed, which further resulted in the production of CBT-ol in the yeast strain BY-T20 with enhanced MVA pathway for geranylgeranyl diphosphate (GGPP) production but not in other yeast strains with low GGPP supply. Subsequently, CBT-diol was also synthesized by co-expression of the modifed enzyme AD-CBTS1 and BD-CYP450 in the yeast strain BY-T20. Conclusions: We demonstrated that yeast is insensitive to the tobacco anti-fungal compound CBT-ol or CBT-diol and could be applied to their biosynthesis.
    [Show full text]
  • The Genus Solanum: an Ethnopharmacological, Phytochemical and Biological Properties Review
    Natural Products and Bioprospecting (2019) 9:77–137 https://doi.org/10.1007/s13659-019-0201-6 REVIEW The Genus Solanum: An Ethnopharmacological, Phytochemical and Biological Properties Review Joseph Sakah Kaunda1,2 · Ying‑Jun Zhang1,3 Received: 3 January 2019 / Accepted: 27 February 2019 / Published online: 12 March 2019 © The Author(s) 2019 Abstract Over the past 30 years, the genus Solanum has received considerable attention in chemical and biological studies. Solanum is the largest genus in the family Solanaceae, comprising of about 2000 species distributed in the subtropical and tropical regions of Africa, Australia, and parts of Asia, e.g., China, India and Japan. Many of them are economically signifcant species. Previous phytochemical investigations on Solanum species led to the identifcation of steroidal saponins, steroidal alkaloids, terpenes, favonoids, lignans, sterols, phenolic comopunds, coumarins, amongst other compounds. Many species belonging to this genus present huge range of pharmacological activities such as cytotoxicity to diferent tumors as breast cancer (4T1 and EMT), colorectal cancer (HCT116, HT29, and SW480), and prostate cancer (DU145) cell lines. The bio- logical activities have been attributed to a number of steroidal saponins, steroidal alkaloids and phenols. This review features 65 phytochemically studied species of Solanum between 1990 and 2018, fetched from SciFinder, Pubmed, ScienceDirect, Wikipedia and Baidu, using “Solanum” and the species’ names as search terms (“all felds”). Keywords Solanum · Solanaceae
    [Show full text]
  • (12)UK Patent Application (1S1GB ,„>2577037 ,,3,A 2577037
    (12)UK Patent Application (1S1GB ,„>2577037 ,,3,A (43) Date of A Publication 18.03.2020 (21) Application No: 1812997.3 (51) INT CL: C12N 15/52 (2006.01) C12P 33/02 (2006.01) (22) Date of Filing: 09.08.2018 C12R 1/32 (2006.01) C12R 1/365 (2006.01) (56) Documents Cited: GB 2102429 A EP 3112472 A (71) Applicant(s): WO 2001/031050 A US 4345029 A Cambrex Karlskoga AB US 4320195 A (Incorporated in Sweden) Appl Environ Microbiol, published online 4 May 2018, S-691 85 Karlskoga, Sweden Liu et al, "Characterization and engineering of 3- ketosteroid 9a-hydroxylases in Mycobacterium Rijksuniversiteit Groningen neoarum ATCC 25795 for the development of (Incorporated in the Netherlands) androst-1,4- diene3,17-dione and 9a-hydroxy- Broerstraat 5, 9712 CP Groningen, Netherlands androst-4-ene-3,17-dione-producing strains" Appl Environ Microbiol, Vol 77 (2011), Wilbrink et al, (72) Inventor(s): "FadD19 of Rhodococcus rhodochrous DMS43269, a Jonathan Knight steroid-coenzyme A ligase essential for degradation Cecilia Kvarnstrom Branneby of C-24 branched sterol side chains", pp 4455-4464 Lubbert Dijkhuizen FEMS Microbiol Letts, Vol 205 (2001), van der Geize et Janet Maria Petrusma al, "Unmarked gene deletion mutagenesis of kstD, Laura Fernandez De Las Heras encoding 3-ketosteroid deltal-dehydrogenase, in Rhodococcus erythropolis SQ1 using sacB as a counter-selectable marker", pp 197-202 (74) Agent and/or Address for Service: J Steroid Biochem Mol Biol, Vol 172 (2017), Guevara Potter Clarkson LLP et al, "Functional characterization of 3-ketosteroid 9a- The
    [Show full text]
  • Structures and Characteristics of Carbohydrates in Diets Fed to Pigs: a Review Diego M
    Navarro et al. Journal of Animal Science and Biotechnology (2019) 10:39 https://doi.org/10.1186/s40104-019-0345-6 REVIEW Open Access Structures and characteristics of carbohydrates in diets fed to pigs: a review Diego M. D. L. Navarro1, Jerubella J. Abelilla1 and Hans H. Stein1,2* Abstract The current paper reviews the content and variation of fiber fractions in feed ingredients commonly used in swine diets. Carbohydrates serve as the main source of energy in diets fed to pigs. Carbohydrates may be classified according to their degree of polymerization: monosaccharides, disaccharides, oligosaccharides, and polysaccharides. Digestible carbohydrates include sugars, digestible starch, and glycogen that may be digested by enzymes secreted in the gastrointestinal tract of the pig. Non-digestible carbohydrates, also known as fiber, may be fermented by microbial populations along the gastrointestinal tract to synthesize short-chain fatty acids that may be absorbed and metabolized by the pig. These non-digestible carbohydrates include two disaccharides, oligosaccharides, resistant starch, and non-starch polysaccharides. The concentration and structure of non-digestible carbohydrates in diets fed to pigs depend on the type of feed ingredients that are included in the mixed diet. Cellulose, arabinoxylans, and mixed linked β-(1,3) (1,4)-D-glucans are the main cell wall polysaccharides in cereal grains, but vary in proportion and structure depending on the grain and tissue within the grain. Cell walls of oilseeds, oilseed meals, and pulse crops contain cellulose, pectic polysaccharides, lignin, and xyloglucans. Pulse crops and legumes also contain significant quantities of galacto-oligosaccharides including raffinose, stachyose, and verbascose.
    [Show full text]
  • Neonatal Parenteral Nutrition [D3] Lipids
    National Institute for Health and Care Excellence Draft for consultation Neonatal parenteral nutrition [D3] Lipids NICE guideline tbc Evidence reviews September 2019 Draft for Consultation These evidence reviews were developed by the National Guideline Alliance which is part of the Royal College of Obstetricians and Gynaecologists DRAFT FOR CONSULTATION Error! No text of specified style in document. Disclaimer The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties. NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive.
    [Show full text]